Transoceanic Pharmaceutical Development

Transoceanic Pharmaceutical Development (Guangzhou) Co., Ltd. is a specialty pharmaceutical company focused on the development of advanced oral drug delivery systems. The company utilizes its proprietary double-layer and triple-layer controlled-release tablet platforms to optimize the pharmacokinetic profiles of established small molecule therapeutics. Its primary focus areas include hypnotics for sleep disorders, such as zolpidem tartrate, and analgesics for pain management, including combinations like ibuprofen and codeine phosphate. By engineering complex release profiles, such as immediate release followed by sustained release, Transoceanic aims to improve patient compliance and therapeutic efficacy. The company was founded by Wen Xiaoguang and maintains a strong intellectual property portfolio with patents in China, the United States, Europe, and Japan.